查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1660711

心臟生物標記市場報告（按類型（肌鈣蛋白、心肌肌酸激酶、肌紅蛋白、腦鈉肽或 NT-proBNP、缺血修飾白蛋白等）、檢測地點、應用和地區分類，2025 年至 2033 年）

Cardiac Biomarkers Market Report by Type (Troponins, Myocardial Muscle Creatine Kinase, Myoglobin, Brain Natriuretic Peptide or NT-proBNP, Ischemia Modified Albumin, and Others), Location of Testing, Application, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 135 Pages | 商品交期: 2-3個工作天內

價格

2024IMARC Group全球心臟生物標記市場規模達到 115 億美元。

心臟標誌物，也稱為心臟生物標記物，當心臟受到壓力或肌肉受損時就會釋放到血液中。這些標記物包括不同類型的酵素、荷爾蒙和蛋白質，例如心臟肌鈣蛋白、肌酸激酶 (CK)、缺血修飾白蛋白 (IMA) 和肌紅蛋白。這些標記物的測量和測試有助於診斷心臟缺血和急性冠狀動脈症候群（ACS）等心臟疾病。目前，用於確定這些疾病風險的分類和診斷系統是基於心電圖 (ECG) 和臨床病史。然而，這些系統是不夠的，可能會導致誤診或延遲治療。由於心臟標記檢測具有更高的準確性，並且能夠在症狀早期識別病情，因此它們在全球範圍內越來越受歡迎。這些標記物還可以幫助更準確地監測這些病症的預後並為患者提供最有效的治療。

全球心臟生物標記市場促進因素：

在過去幾年中，患有 ACS 的患者數量有所增加，這在全球範圍內導致了對心臟標記檢測的需求。除此之外，患者和醫療保健提供者對早期診斷各種心血管疾病的重要性的認知不斷提高，推動了對這些標記物的需求。此外，還有許多私人和公共組織正在投資研發活動，以開發心臟生物標記領域的先進技術。例如，已證明高敏感性心肌肌鈣蛋白I的血液檢測可以識別出再次心臟病發作風險較高的患者。此外，生物標記檢測提供的高精度和快速結果，加上價格合理的心臟即時檢測的可用性，也是推動市場成長的其他因素。

本報告解答的關鍵問題

  • 2024 年全球心臟生物標記市場規模？ 2025 年至 2033 年期間全球心臟生物標記市場的預期成長率為何？
  • 推動全球心臟生物標記市場發展的關鍵因素有哪些？
  • COVID-19 對全球心臟生物標記市場有何影響？
  • 根據檢測地點，全球心臟生物標記市場如何分佈？
  • 根據應用，全球心臟生物標記市場如何分佈？
  • 全球心臟生物標記市場的關鍵區域有哪些？
  • 全球心臟生物標記市場的關鍵公司/參與者有哪些？

目錄

第 1 章：前言

第 2 章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球心臟生物標記市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場區隔：按類型
  • 市場區隔：依測試地點分類
  • 市場區隔：按應用
  • 市場分佈：按地區
  • 市場預測

第6章：市場細分：依類型

  • 肌鈣蛋白（T 和 I）
    • 市場趨勢
    • 市場預測
  • 心肌肌酸激酶（CK-MB）
    • 市場趨勢
    • 市場預測
  • 肌紅蛋白
    • 市場趨勢
    • 市場預測
  • 腦鈉肽 (BNPs) 或 NT-proBNP
    • 市場趨勢
    • 市場預測
  • 缺血修飾白蛋白 (IMA)
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第7章：市場區隔：依測試地點分類

  • 實驗室測試
    • 市場趨勢
    • 市場預測
  • 即時檢驗
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：按應用

  • 心肌梗塞
    • 市場趨勢
    • 市場預測
  • 充血性心臟衰竭
    • 市場趨勢
    • 市場預測
  • 急性冠狀動脈綜合症
    • 市場趨勢
    • 市場預測
  • 動脈粥狀硬化
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第9章：市場細分：依地區

  • 北美洲
    • 市場趨勢
    • 市場預測
  • 亞太地區
    • 市場趨勢
    • 市場預測
  • 歐洲
    • 市場趨勢
    • 市場預測
  • 中東和非洲
    • 市場趨勢
    • 市場預測
  • 拉丁美洲
    • 市場趨勢
    • 市場預測

第 10 章：全球心臟生物標記產業：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 11 章：全球心臟生物標記產業：價值鏈分析

第 12 章：全球心臟生物標記產業：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 13 章：全球心臟生物標記產業：價格分析

第 14 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • Abbott Laboratories
    • Alere Inc.
    • Beckman Coulter
    • Becton, Dickinson And Co.
    • Biomerieux
    • Bio-Rad Laboratories
    • Randox Laboratories
    • Roche Diagnostics Corporation
    • Siemens Healthcare
    • Thermo Fisher Scientific
Product Code: SR112025A1178

The global cardiac biomarkers market size reached USD 11.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 22.2 Billion by 2033, exhibiting a growth rate (CAGR) of 7.22% during 2025-2033.

Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.

Global Cardiac Biomarkers Market Drivers:

Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.

Key Market Segmentation:

Breakup by Type:

  • Troponins (T and I)
  • Myocardial Muscle Creatine Kinase (CK-MB)
  • Myoglobin
  • Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • Ischemia Modified Albumin (IMA)
  • Others

Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.

Breakup by Location of Testing:

  • Laboratory Testing
  • Point of Care Testing

Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.

Breakup by Application:

  • Myocardial Infarction
  • Congestive Heart Failure
  • Acute Coronary Syndrome
  • Atherosclerosis
  • Others

Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.

Regional Insights:

  • North America
  • Asia Pacific
  • Europe
  • Middle East and Africa
  • Latin America
  • Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.

Competitive Landscape:

  • The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.

Key Questions Answered in This Report

  • 1.What was the size of the global cardiac biomarkers market in 2024?
  • 2.What is the expected growth rate of the global cardiac biomarkers market during 2025-2033?
  • 3.What are the key factors driving the global cardiac biomarkers market?
  • 4.What has been the impact of COVID-19 on the global cardiac biomarkers market?
  • 5.What is the breakup of the global cardiac biomarkers market based on the location of testing?
  • 6.What is the breakup of the global cardiac biomarkers market based on the application?
  • 7.What are the key regions in the global cardiac biomarkers market?
  • 8.Who are the key companies/players in the global cardiac biomarkers market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Cardiac Biomarkers Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Breakup by Type
  • 5.5 Market Breakup by Location of Testing
  • 5.6 Market Breakup by Application
  • 5.7 Market Breakup by Region
  • 5.8 Market Forecast

6 Market Breakup by Type

  • 6.1 Troponins (T and I)
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Myocardial Muscle Creatine Kinase (CK-MB)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Myoglobin
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Ischemia Modified Albumin (IMA)
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Location of Testing

  • 7.1 Laboratory Testing
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Point of Care Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Myocardial Infarction
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Congestive Heart Failure
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Acute Coronary Syndrome
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Atherosclerosis
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Asia Pacific
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Middle East and Africa
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Latin America
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Global Cardiac Biomarkers Industry: SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Global Cardiac Biomarkers Industry: Value Chain Analysis

12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Global Cardiac Biomarkers Industry: Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Abbott Laboratories
    • 14.3.2 Alere Inc.
    • 14.3.3 Beckman Coulter
    • 14.3.4 Becton, Dickinson And Co.
    • 14.3.5 Biomerieux
    • 14.3.6 Bio-Rad Laboratories
    • 14.3.7 Randox Laboratories
    • 14.3.8 Roche Diagnostics Corporation
    • 14.3.9 Siemens Healthcare
    • 14.3.10 Thermo Fisher Scientific

List of Figures

  • Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
  • Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2024
  • Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2024
  • Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2024
  • Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
  • Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
  • Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
  • Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million USD), 2025-2033

List of Tables

  • Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million USD), 2025-2033
  • Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Cardiac Biomarkers Market Structure
  • Table 7: Global: Cardiac Biomarkers Market: Key Players